Your browser doesn't support javascript.
loading
Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Giebel, Sebastian; Labopin, Myriam; Salmenniemi, Urpu; Socié, Gerard; Bondarenko, Sergey; Blaise, Didier; Kröger, Nicolaus; Vydra, Jan; Grassi, Anna; Bonifazi, Francesca; Czerw, Tomasz; Anagnostopoulos, Achilles; Lioure, Bruno; Ruggeri, Annalisa; Savani, Bipin; Spyridonidis, Alexandros; Sanz, Jaime; Peric, Zinaida; Nagler, Arnon; Ciceri, Fabio; Mohty, Mohamad.
Afiliação
  • Giebel S; Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland.
  • Labopin M; Department of Hematology and Cellular Therapy, National Institute of Health and Medical Research Unit UMR-S 938, Sorbonne University and St Anthony Scientific Research Center, Public Assistance Hospital of Paris, St Anthony Hospital, Paris, France.
  • Salmenniemi U; European Society for Blood and Marrow Transplantation Paris Study Office/CEREST-TC, Paris, France.
  • Socié G; Stem Cell Transplantation Unit, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.
  • Bondarenko S; Hematology, National Institute of Health and Medical Research Unit U976, Public Assistance Hospital of Paris, St Louis Hospital, University of Paris, Paris, France.
  • Blaise D; RM Gorbacheva Research Institute, Pavlov University, St Petersburg, Russia.
  • Kröger N; Transplantation and Cellular Therapy Program, Cancer Research Center of Marseille, Paoli Calmettes Institute, Marseille, France.
  • Vydra J; Bone Marrow Transplantation Center, Eppendorf University Hospital, Hamburg, Germany.
  • Grassi A; Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Bonifazi F; Department of Hematology, Hospital "Papa Giovanni XXIII", Bergamo, Italy.
  • Czerw T; Institute of Hematology "L. e A. Seràgnoli", IRCCS University Hospital, Bologna, Italy.
  • Anagnostopoulos A; Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland.
  • Lioure B; Hematopoietic Cell Transplantation Unit, Hematology Department, G. Papanikolaou Hospital, Thessaloniki, Greece.
  • Ruggeri A; New Civil Hospital, Strasbourg, France.
  • Savani B; IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Spyridonidis A; Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Sanz J; University Hospital of Patras, Patras, Greece.
  • Peric Z; Bone Marrow Transplant Unit, Department of Hematology, La Fe University and Polytechnic Hospital, Valencia, Spain.
  • Nagler A; University of Zagreb School of Medicine, Zagreb, Croatia.
  • Ciceri F; Hematology Division, Chaim Sheba Medical Center, Ramat Gan, Israel.
  • Mohty M; IRCCS San Raffaele Scientific Institute, Milan, Italy.
Cancer ; 129(23): 3735-3745, 2023 12 01.
Article em En | MEDLINE | ID: mdl-37658621
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: Cancer Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Polônia